
NuVasive NUVA
Quarterly report 2023-Q2
added 08-02-2023
NuVasive P/CF Ratio 2011-2026 | NUVA
Annual P/CF Ratio NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.5 | 14.7 | 14.9 | 39 | 22.8 | 38.2 | 56.2 | -118 | 37.9 | 33.9 | 8.45 | 65.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 65.7 | -118 | 19 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
18.9 | $ 185.02 | -0.81 % | $ 13.9 B | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 38.94 | -1.37 % | $ 5.8 K | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
2 | $ 12.58 | -0.55 % | $ 1.7 B | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.61 | 3.18 % | $ 38 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.59 | 1.99 % | $ 134 M | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 63.42 | -1.83 % | $ 93.9 B | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
-13.2 | $ 10.5 | 0.38 % | $ 297 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
15.3 | $ 25.39 | -1.24 % | $ 215 M | ||
|
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
LENSAR
LNSR
|
-4.81 | $ 5.8 | -7.2 % | $ 69.4 M | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 16.53 | -7.39 % | $ 388 M | ||
|
Globus Medical
GMED
|
16.6 | $ 92.76 | -1.87 % | $ 12.5 B | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.06 | 6.19 % | $ 1.25 M | ||
|
Butterfly Network
BFLY
|
-18.4 | $ 5.29 | 8.74 % | $ 1.12 B | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
Inogen
INGN
|
-14.3 | $ 6.59 | 6.29 % | $ 175 M | ||
|
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.04 | - | $ 17.6 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
14.5 | $ 10.83 | -1.46 % | $ 388 M | ||
|
Inspire Medical Systems
INSP
|
15.1 | $ 56.45 | -0.34 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 37.91 | -3.88 % | $ 1.18 B | ||
|
LivaNova PLC
LIVN
|
15 | $ 65.01 | -0.2 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
15.2 | $ 88.37 | 0.49 % | $ 3.07 B | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.76 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
30.6 | $ 79.05 | 1.09 % | $ 46.2 B | ||
|
Sintx Technologies
SINT
|
-0.806 | $ 2.68 | -2.19 % | $ 7.43 M | ||
|
Penumbra
PEN
|
55.3 | $ 331.47 | -0.29 % | $ 12.9 B |